Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cesarean Section | 5 | 2021 | 140 | 1.330 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 44 | 0.920 |
Why?
|
| Anesthesia, Epidural | 1 | 2024 | 32 | 0.910 |
Why?
|
| Fetus | 1 | 2024 | 232 | 0.850 |
Why?
|
| Anesthesia | 1 | 2024 | 169 | 0.800 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 233 | 0.760 |
Why?
|
| Uterus | 1 | 2021 | 222 | 0.660 |
Why?
|
| Anesthesia, Intravenous | 1 | 2018 | 35 | 0.620 |
Why?
|
| Anesthesia, Conduction | 1 | 2018 | 18 | 0.620 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2018 | 71 | 0.580 |
Why?
|
| Anesthesia, General | 1 | 2018 | 118 | 0.580 |
Why?
|
| Uterine Contraction | 1 | 2016 | 9 | 0.540 |
Why?
|
| Oxytocics | 1 | 2016 | 23 | 0.530 |
Why?
|
| Myometrium | 1 | 2016 | 51 | 0.520 |
Why?
|
| Oxytocin | 1 | 2016 | 72 | 0.500 |
Why?
|
| Renal Dialysis | 1 | 2018 | 335 | 0.500 |
Why?
|
| Length of Stay | 1 | 2018 | 733 | 0.480 |
Why?
|
| Pregnancy | 8 | 2024 | 3011 | 0.460 |
Why?
|
| Pain, Postoperative | 4 | 2021 | 251 | 0.450 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 442 | 0.360 |
Why?
|
| Postoperative Complications | 1 | 2018 | 2278 | 0.300 |
Why?
|
| Fetal Monitoring | 1 | 2024 | 19 | 0.230 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2024 | 28 | 0.230 |
Why?
|
| Catheters | 1 | 2024 | 76 | 0.230 |
Why?
|
| Female | 10 | 2024 | 46078 | 0.220 |
Why?
|
| Anesthetics | 1 | 2024 | 53 | 0.220 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 599 | 0.210 |
Why?
|
| Spinal Cord | 1 | 2024 | 255 | 0.210 |
Why?
|
| Medicine | 1 | 2022 | 91 | 0.200 |
Why?
|
| Surgical Procedures, Operative | 1 | 2024 | 206 | 0.190 |
Why?
|
| Labor, Obstetric | 1 | 2021 | 46 | 0.190 |
Why?
|
| Abdominal Muscles | 1 | 2020 | 19 | 0.190 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 345 | 0.190 |
Why?
|
| Bupivacaine | 1 | 2020 | 45 | 0.180 |
Why?
|
| Nerve Block | 1 | 2020 | 50 | 0.180 |
Why?
|
| Anesthetics, Local | 1 | 2020 | 76 | 0.180 |
Why?
|
| Patient Discharge | 1 | 2021 | 320 | 0.150 |
Why?
|
| Humans | 10 | 2024 | 89157 | 0.150 |
Why?
|
| Adult | 7 | 2024 | 26542 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1043 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2018 | 684 | 0.130 |
Why?
|
| Reoperation | 1 | 2018 | 598 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 988 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 461 | 0.130 |
Why?
|
| Physicians | 1 | 2022 | 690 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2753 | 0.120 |
Why?
|
| Logistic Models | 1 | 2018 | 1213 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2018 | 851 | 0.120 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 996 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1940 | 0.100 |
Why?
|
| Time Factors | 1 | 2018 | 5331 | 0.080 |
Why?
|
| United States | 2 | 2018 | 6965 | 0.080 |
Why?
|
| Risk Factors | 1 | 2018 | 5483 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2016 | 4281 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8217 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2018 | 9022 | 0.060 |
Why?
|
| Middle Aged | 2 | 2020 | 25910 | 0.050 |
Why?
|
| Liposomes | 1 | 2020 | 93 | 0.050 |
Why?
|
| Aged | 1 | 2018 | 19119 | 0.050 |
Why?
|
| Tablets | 1 | 2021 | 121 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 322 | 0.040 |
Why?
|
| Massachusetts | 1 | 2019 | 32 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 106 | 0.040 |
Why?
|
| Maternal Health Services | 1 | 2017 | 16 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2019 | 328 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2022 | 625 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 242 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1715 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2017 | 335 | 0.030 |
Why?
|
| Male | 1 | 2018 | 42309 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 447 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2614 | 0.030 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 185 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 6294 | 0.020 |
Why?
|